Literature DB >> 18622028

Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo.

Nigora Mukhamedova1, Genevieve Escher, Wilissa D'Souza, Urbain Tchoua, Angela Grant, Zigmund Krozowski, Michael Bukrinsky, Dmitri Sviridov.   

Abstract

Eight proteins potentially involved in cholesterol efflux [ABCA1, ABCG1, CYP27A1, phospholipid transfer protein (PLTP), scavenger receptor type BI (SR-BI), caveolin-1, cholesteryl ester transfer protein, and apolipoprotein A-I (apoA-I)] were overexpressed alone or in combination in RAW 264.7 macrophages. When apoA-I was used as an acceptor, overexpression of the combination of ABCA1, CYP27A1, PLTP, and SR-BI (Combination I) enhanced the efflux by 4.3-fold. It was established that the stimulation of efflux was due to increased abundance of ABCA1 and increased apoA-I binding to non-ABCA1 sites on macrophages. This combination caused only a small increase of the efflux to isolated HDL. When HDL was used as an acceptor, overexpression of caveolin-1 or a combination of caveolin-1 and SR-BI (Combination II) was the most active, doubling the efflux to HDL, without affecting the efflux to apoA-I. When tested in the in vivo mouse model of cholesterol efflux, overexpression of ABCA1 and Combination I elevated cholesterol export from macrophages to plasma, liver, and feces, whereas overexpression of caveolin-1 or Combination II did not have an effect. We conclude that pathways of cholesterol efflux using apoA-I as an acceptor make a predominant contribution to cholesterol export from macrophages in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622028      PMCID: PMC5475370          DOI: 10.1194/jlr.M800095-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  42 in total

1.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

2.  Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.

Authors:  Babak Razani; Terry P Combs; Xiao Bo Wang; Philippe G Frank; David S Park; Robert G Russell; Maomi Li; Baiyu Tang; Linda A Jelicks; Philipp E Scherer; Michael P Lisanti
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

3.  Characterization of the maturation of human pro-apolipoprotein A-I in an in vitro model.

Authors:  L E Pyle; D Sviridov; N H Fidge
Journal:  Biochemistry       Date:  2001-03-13       Impact factor: 3.162

4.  ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions.

Authors:  Ashley M Vaughan; John F Oram
Journal:  J Lipid Res       Date:  2003-04-16       Impact factor: 5.922

5.  A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1.

Authors:  P E Fielding; K Nagao; H Hakamata; G Chimini; C J Fielding
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

6.  Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux.

Authors:  Genevieve Escher; Zygmunt Krozowski; Kevin D Croft; Dmitri Sviridov
Journal:  J Biol Chem       Date:  2003-01-16       Impact factor: 5.157

7.  Expression of caveolin-1 enhances cholesterol efflux in hepatic cells.

Authors:  Ying Fu; Anh Hoang; Genevieve Escher; Robert G Parton; Zygmunt Krozowski; Dmitri Sviridov
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

8.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

Authors:  Xun Wang; Heidi L Collins; Mollie Ranalletta; Ilia V Fuki; Jeffrey T Billheimer; George H Rothblat; Alan R Tall; Daniel J Rader
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

9.  The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.

Authors:  Urbain Tchoua; Wilissa D'Souza; Nigora Mukhamedova; Denise Blum; Eric Niesor; Jacques Mizrahi; Cyrille Maugeais; Dmitri Sviridov
Journal:  Cardiovasc Res       Date:  2007-12-04       Impact factor: 10.787

10.  Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects.

Authors:  Giovanna Catalano; Emilie Duchene; Zélie Julia; Wilfried Le Goff; Eric Bruckert; M John Chapman; Maryse Guerin
Journal:  J Lipid Res       Date:  2007-12-05       Impact factor: 5.922

View more
  24 in total

1.  Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.

Authors:  Urbain Tchoua; Corina Rosales; Daming Tang; Baiba K Gillard; Ashley Vaughan; Hu Yu Lin; Harry S Courtney; Henry J Pownall
Journal:  Lipids       Date:  2010-10-24       Impact factor: 1.880

2.  5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.

Authors:  Marcelo J A Amar; Wilissa D'Souza; Scott Turner; Stephen Demosky; Denis Sviridov; John Stonik; Jayraz Luchoomun; Jason Voogt; Marc Hellerstein; Dmitri Sviridov; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2010-05-19       Impact factor: 4.030

3.  Tweaking the cholesterol efflux capacity of reconstituted HDL.

Authors:  Cheng-I J Ma; Jennifer A Beckstead; Airlia Thompson; Anouar Hafiane; Rui Hao Leo Wang; Robert O Ryan; Robert S Kiss
Journal:  Biochem Cell Biol       Date:  2012-05-18       Impact factor: 3.626

4.  Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.

Authors:  Madhuri Vasudevan; Urbain Tchoua; Baiba K Gillard; Peter H Jones; Christie M Ballantyne; Henry J Pownall
Journal:  J Clin Lipidol       Date:  2013-05-25       Impact factor: 4.766

5.  Cholesterol efflux assay.

Authors:  Hann Low; Anh Hoang; Dmitri Sviridov
Journal:  J Vis Exp       Date:  2012-03-06       Impact factor: 1.355

Review 6.  SR-BI: A Multifunctional Receptor in Cholesterol Homeostasis and Atherosclerosis.

Authors:  MacRae F Linton; Huan Tao; Edward F Linton; Patricia G Yancey
Journal:  Trends Endocrinol Metab       Date:  2017-03-01       Impact factor: 12.015

7.  Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE-knockout mice.

Authors:  Line Zurkinden; Curzio Solcà; Isabelle A Vögeli; Bruno Vogt; Daniel Ackermann; Sandra K Erickson; Felix J Frey; Dmitri Sviridov; Geneviève Escher
Journal:  FASEB J       Date:  2013-12-10       Impact factor: 5.191

Review 8.  ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.

Authors:  Dimitry A Chistiakov; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Lab Invest       Date:  2016-05-16       Impact factor: 5.662

9.  HDL superphospholipidation enhances key steps in reverse cholesterol transport.

Authors:  Urbain Tchoua; Baiba K Gillard; Henry J Pownall
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

10.  Haptoglobin inhibits phospholipid transfer protein activity in hyperlipidemic human plasma.

Authors:  Ryan J Henderson; Kishor M Wasan; Carlos G Leon
Journal:  Lipids Health Dis       Date:  2009-07-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.